The ACC and Butterfly Network are joining forces to transform the use of ultrasound within cardiology using a next-generation ultrasound product, Butterfly iQ+ – the world's only single-probe, whole-body ultrasound system that connects to a mobile device and features an integrated telemedicine platform.

An estimated 6.2 million adults in the United States have heart failure, according to the Center for Disease Control, and it is a leading cause of mortality and morbidity. Currently, there are more than one million hospitalizations of patients with exacerbation of heart failure, and 25% of those patients are readmitted within 30 days. The ACC and Butterfly Network will attempt to change this by collaborating on a clinical trial that leverages Butterfly's innovative technology for at-home ultrasound scanning.

"Our collaboration with the ACC will help us design clinical trials and care pathways for some of the more challenging heart diseases and accelerate the adoption of point-of-care ultrasound by cardiovascular clinicians," said John Martin, MD, Butterfly Network's Chief Medical Officer. "One of the key targets is heart failure, with a goal to radically change monitoring. If patients can assess their status at home via AI-guided lung scans with their clinician or care team remotely, we can avoid unnecessary and costly hospital visits. This will also provide patients with more timely intervention, improve quality of care, and improve their quality of life."

Butterfly Network has long recognized that the key to unlocking the value of ultrasound is to remove the barriers of cost and complexity in traditional systems through innovation. ACC's strategic investment in Butterfly Network and collaboration on clinical trials will increase access to point-of-care ultrasound in the management of critical cardiovascular diseases.

"Through innovative collaborations like this – directly linking the technology and clinical worlds – the ACC aims to transform cardiovascular care and improve health outcomes," said John S. Rumsfeld, MD, PhD, FACC, ACC's Chief Science and Chief Innovation Officer. "The ACC will work in sync with Butterfly to help guide the scientific evaluation and clinical integration of point-of-care ultrasound in the management of cardiovascular conditions."

"We're thrilled to be working with the ACC to transform cardiovascular care together, especially in the critical area of congestive heart failure, for better care, better outcomes, and lower cost to all constituents," adds Laurent Faracci, Butterfly Network's Chief Executive Officer.

Clinical Topics: Heart Failure and Cardiomyopathies, Noninvasive Imaging, Acute Heart Failure, Echocardiography/Ultrasound

Keywords: Cardiovascular Diseases, Point-of-Care Systems, Quality of Life, Cardiology, Heart Failure, Heart Diseases, Ultrasonography, Hospitalization, Telemedicine, Centers for Disease Control and Prevention, U.S., Quality of Health Care, Outcome Assessment, Health Care, Innovation

< Back to Listings